Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 100 clinical trials
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

This is a Phase I, first-in-human study to evaluate the safety and efficacy of the [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G theranostic pair in patients with locally advanced or metastatic pancreatic adenocarcinoma (PDAC).

  • 0 views
  • 13 May, 2022
  • 1 location
PanDox: Targeted Doxorubicin in Pancreatic Tumours (PanDox)

This study will combine focused ultrasound to generate heat, and a heat-sensitive chemotherapy drug (ThermoDox®), delivered into the blood of participants with non-resectable pancreatic cancer. We will compare this to standard delivery of chemotherapy - the drug Doxorubicin given into the blood without the addition of ultrasound. We aim to …

  • 0 views
  • 14 Mar, 2022
  • 1 location
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for First and Second Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer

chemotherapy in combination with aldoxorubicin HCl, N-803, and PD-L1 t-haNK in subjects with locally advanced or metastatic pancreatic cancer. Each treatment setting (ie, first line maintenance, second line

metastatic pancreatic cancer
cancer chemotherapy
folfirinox
irinotecan
leucovorin
  • 0 views
  • 01 May, 2022
  • 4 locations
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) (CTC-AXL-PANC)

In solid cancers, some more aggressive tumor cells actively detach from the primary lesion and then travel through the circulating compartment to reach distant organs and form micro-metastases. These circulating tumor cells (CTCs) that have become disseminated tumor cells (DTCs) flourish in their new environments and may remain dormant for …

breast cancer
adenocarcinoma
tumor cells
tyrosine
cancer
  • 0 views
  • 25 Jul, 2022
  • 1 location
RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer

This is a Phase I, multi center study to evaluate the safety and efficacy and determine the maximum tolerated dose (MTD) of RP72 as monotherapy and RP72 in combination with Gemcitabine in patients with pancreatic cancer. The study has two arms: Arm A: RP72 monotherapy Arm B: RP72 in combination …

metastatic pancreatic cancer
chemotherapy drug
cancer chemotherapy
thromboplastin
gemcitabine
  • 0 views
  • 28 Jun, 2021
  • 2 locations
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer

To evaluate the normalization rate of CA 19-9 of individuals with non-metastatic pancreas cancer following up to 6 months of neoadjuvant chemotherapy.

  • 0 views
  • 30 May, 2022
  • 1 location
TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma

pancreatic cancer patients.

metastatic pancreatic cancer
adenocarcinoma
cancer chemotherapy
measurable disease
pancreatic adenocarcinoma
  • 0 views
  • 28 Jul, 2022
  • 1 location
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

maintenance therapy in patients with metastatic pancreatic cancer.

metastatic pancreatic cancer
carcinoma
adenocarcinoma
cancer chemotherapy
gemcitabine
  • 0 views
  • 27 Apr, 2022
  • 1 location
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

, patients with refractory, metastatic pancreatic cancer will receive combination cabozantinib + atezolizumab and the efficacy of this treatment will be assessed through overall response rate (ORR), disease

metastatic pancreatic cancer
  • 0 views
  • 27 Dec, 2021
  • 1 location
Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

The study will perform a clinical study evaluating the safety and tolerability of nintedanib when combined with standard chemotherapy (Gemcitabine + nab-Paclitaxel) for metastatic pancreatic

metastatic pancreatic cancer
adenocarcinoma
cancer chemotherapy
drainage
obstruction
  • 22 views
  • 27 Feb, 2022
  • 1 location